Key result
AZIMUTH evaluates feasibility of a smartphone app-based care model versus standard care in HF.
Why the study?
Despite advancements in disease-modifying therapies, heart failure hospitalization rates remain high with increased risk of adverse events and healthcare costs.
Does a smartphone app-based model of care improve feasibility, usability, and perceived benefits compared to standard of care in heart failure patients?
Cohort (n=300)
Yes
Does a smartphone app-based model of care improve feasibility, usability, and perceived benefits compared to standard of care in heart failure patients?
The AZIMUTH trial will evaluate whether a smartphone app-based model of care is feasible and beneficial for heart failure patients compared to historical and propensity-matched standard of care cohorts.
Answers are grounded in this paper and cite their sources.
Supports app-based HF care feasibility; leaves open readmission benefits without randomized confirmation.
Aims: Despite advancements in disease-modifying therapies, the rate of hospitalizations in patients with heart failure (HF) remains high, with an increased risk of future adverse events and healthcare costs. In this context, the AZIMUTH study aims to evaluate the large-scale applicability of a smartphone app-based model of care to improve the quality of care and clinical outcomes of HF patients. Methods and results: The AZIMUTH trial is a multicentre, prospective, pragmatic, interventional, single-cohort study enrolling HF patients. Three hundred patients will be recruited from four different sites. For comparative analyses, historical data from participating hospitals for the 6 months before enrolment and propensity-matching score analyses from GENERATOR HF DataMart, will be used. The estimated duration of the study is 6 months. During the whole observational period, the patients are asked to provide information regarding their clinical status, transmit remote clinical parameters, and periodically answer validated questionnaires, the Kansas City Cardiomyopathy Questionnaire Health and Morisky Medication Adherence Scale 8-item, on a mobile application, through which healthcare providers implement therapeutic adjustments and remote clinical assessments. The primary objective of this study is to evaluate the feasibility, usability, and perceived benefits for key stakeholders (patients and clinical staff) of the AZIMUTH digital platform in the enrolled patients when compared to standard of care. Secondary endpoints will be the description of the rate of hospital readmissions, ambulatory visits and prescribed therapy in the 6 months following enrolment in the experimental group compared to both the historical and propensity-matched cohorts. Conclusion: The AZIMUTH aims to enhance HF management by leveraging digital technologies to support the care process and enhance monitoring, engagement, and personalized treatment for HF patients.
No takes yet. Share an insight, caveat, or question.
D’Amario et al. (2025) conducted a cohort in Heart failure (n=300). AZIMUTH digital platform (smartphone app-based model of care) vs. Standard of care (historical data and propensity-matched cohorts) was evaluated on Feasibility, usability, and perceived benefits for key stakeholders (patients and clinical staff). The AZIMUTH trial is designed to evaluate the feasibility and usability of a smartphone app-based model of care compared to standard of care in 300 patients with heart failure over 6 months.
Synapse has enriched 10 related papers. Consider them for comparative context: